Nova Patents
ES2075005T3

Modified human G-CSF.

Abstract

A MODIFIED POLYPEPTIC PRESENTING A STIMULATING FACTOR ACTIVITY OF THE HUMAN GRANULOCYTIC COLONY (HG - CSF) INCLUDES A POLYPEPTIDE THAT HAS HG - CSF ACTIVITY WITH AT LEAST ONE AMINO GROUP REPLACED WITH A GROUP RESPONDING TO THE FORMULA 1 (FORMULA I) IT IS AN ALKYL OR ALCANOYL GROUP, N IS A WHOLE POSITIVE NUMBER THAT MAY VARY OPTIONALLY; X ES 0, NH OS; R2 IS (FORMULA II): (WHERE R3 IS - OH, CL, O - (CH2CH2O) N - R1, WHERE R1 AND N RESPOND TO THE ABOVE DEFINITION, AND MAY BE Z - (CH2) PCO, WHERE Z IS O, SO NH AND P IS A VARIABLE POSITIVE INTEGER OPTIONALLY, OR NOT BEING PRESENT), O (CO) M - (CH2) L CO, WHERE M IS 0 OR 1, L IS AN INTEGRELY OPTIONALLY VARIABLE POSITIVE, WHICH MAY CONTRIBUTE WITH A GREATER INCREASE EFFECT IN PERIPHERAL LEUKOCYTES (GRANULOCYTES ) WITH GREATER STABILITY AND TIME OF REMAINING IN THE BLOOD AND, AS SUCH, IT CAN BE USEFULLY USED IN CLINICAL MEDICINE.

Term

Term ended

Projected expiry passed 31 March 2009, 17.5 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

72 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims5

Priority claims
DocumentOfficeKindDate
19880080088Japan
8008888JapanA
8008888JapanA
89105728
JP19880080088

Members72

Family members, oldest first
DocumentOfficeKind
DK680987D0DenmarkD0
NO875378D0NorwayD0
PT86465APortugalA
DK680987ADenmarkA
NO875378LNorwayL
NO940495LNorwayL
EP0272703A1European Patent Office (EPO)A1
KR880007734ARepublic of KoreaA
JPS63267292AJapanA
EP0331186A2European Patent Office (EPO)A2
JPH01225495AJapanA
EP0335423A2European Patent Office (EPO)A2
AU3234189AAustraliaA
JPH01316400AJapanA
EP0331186A3European Patent Office (EPO)A3
PT86465BPortugalB
EP0335423A3European Patent Office (EPO)A3
AU620385B2AustraliaB2
AU1703292AAustraliaA
US5194592AUnited States of AmericaA
US5214132AUnited States of AmericaA
EP0272703B1European Patent Office (EPO)B1
AU640567B2AustraliaB2
DE3786767D1GermanyD1
DE3786767T2GermanyT2
JPH068317B2JapanB2
NO940495D0NorwayD0
JPH0692994AJapanA
EP0331186B1European Patent Office (EPO)B1
DE68917338D1GermanyD1
US5362853AUnited States of AmericaA
ES2059354T3SpainT3
NO176799BNorwayB
DE68917338T2GermanyT2
NO176799CNorwayC
JPH07149798AJapanA
EP0335423B1European Patent Office (EPO)B1
AT126235TAustriaT
DE68923723D1GermanyD1
CA1337050CCanadaC
ES2075005T3This recordSpainT3
JPH0796558B2JapanB2
HK164195AHong Kong, ChinaA
GR3017188T3GreeceT3
HU211935A9HungaryA9
HU211958A9HungaryA9
DE68923723T2GermanyT2
HK59396AHong Kong, ChinaA
KR960016560B1Republic of KoreaB1
LV11692ALatviaA
JP2618618B2JapanB2
JP2628961B2JapanB2
LV11692BLatviaB
EP0272703B2European Patent Office (EPO)B2
US5681720AUnited States of AmericaA
JP2673099B2JapanB2
US5714581AUnited States of AmericaA
JPH1052281AJapanA
ES2059354T5SpainT5
DE3786767T3GermanyT3
JP2766798B2JapanB2
US5795968AUnited States of AmericaA
CA1340810CCanadaC
US5994518AUnited States of AmericaA
US6027720AUnited States of AmericaA
BR1100729ABrazilA
DK174044B1DenmarkB1
EP0335423B2European Patent Office (EPO)B2
NO315003B1NorwayB1
ES2075005T5SpainT5
DE68923723T3GermanyT3
CA1341522CCanadaC